August 7, 2026

Suro Senen

Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer breakthrough-in-precision-oncology-fda-approves-trodelvy-for-metastatic-triple-negative-breast-cancer

Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer

Suro Senen July 4, 2026
The landscape of breast cancer treatment has undergone a seismic shift following the recent announcement from the...
Read More Read more about Breakthrough in Precision Oncology: FDA Approves Trodelvy for Metastatic Triple-Negative Breast Cancer
Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care bridging-the-coverage-gap-the-advancing-womens-health-coverage-act-seeks-to-modernize-post-mastectomy-care

Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care

Suro Senen July 1, 2026
ARLINGTON HEIGHTS, IL — For millions of women across the United States, a breast cancer diagnosis is...
Read More Read more about Bridging the Coverage Gap: The Advancing Women’s Health Coverage Act Seeks to Modernize Post-Mastectomy Care
Paradigm Shift in Cancer Therapy: UMass Chan Scientists Uncover Novel Vulnerability in BRCA Mutant Cells paradigm-shift-in-cancer-therapy-umass-chan-scientists-uncover-novel-vulnerability-in-brca-mutant-cells

Paradigm Shift in Cancer Therapy: UMass Chan Scientists Uncover Novel Vulnerability in BRCA Mutant Cells

Suro Senen June 30, 2026
WORCESTER, MA – [Date of Publication] – In a discovery poised to redefine strategies for treating some...
Read More Read more about Paradigm Shift in Cancer Therapy: UMass Chan Scientists Uncover Novel Vulnerability in BRCA Mutant Cells
Major Breakthrough in Prostate Cancer Treatment: Dual-Drug Therapy Significantly Slows Disease Progression for Men with Specific Genetic Mutations major-breakthrough-in-prostate-cancer-treatment-dual-drug-therapy-significantly-slows-disease-progression-for-men-with-specific-genetic-mutations

Major Breakthrough in Prostate Cancer Treatment: Dual-Drug Therapy Significantly Slows Disease Progression for Men with Specific Genetic Mutations

Suro Senen June 30, 2026
LONDON, UK – A landmark international study, spearheaded by researchers at University College London (UCL), has unveiled...
Read More Read more about Major Breakthrough in Prostate Cancer Treatment: Dual-Drug Therapy Significantly Slows Disease Progression for Men with Specific Genetic Mutations
A Unified Shield: Africa CDC and WHO Launch $518 Million Continental Strategy to Combat Bundibugyo Ebola Outbreak a-unified-shield-africa-cdc-and-who-launch-518-million-continental-strategy-to-combat-bundibugyo-ebola-outbreak

A Unified Shield: Africa CDC and WHO Launch $518 Million Continental Strategy to Combat Bundibugyo Ebola Outbreak

Suro Senen June 27, 2026
By Global Health Correspondent In an unprecedented display of regional and international solidarity, the Africa Centres for...
Read More Read more about A Unified Shield: Africa CDC and WHO Launch $518 Million Continental Strategy to Combat Bundibugyo Ebola Outbreak
Ionis Pharmaceuticals Secures Landmark FDA Approval for Tryngolza, Signaling a New Era of Commercial Independence ionis-pharmaceuticals-secures-landmark-fda-approval-for-tryngolza-signaling-a-new-era-of-commercial-independence

Ionis Pharmaceuticals Secures Landmark FDA Approval for Tryngolza, Signaling a New Era of Commercial Independence

Suro Senen June 27, 2026
In a watershed moment for the biotechnology sector, Ionis Pharmaceuticals has received a critical label expansion from...
Read More Read more about Ionis Pharmaceuticals Secures Landmark FDA Approval for Tryngolza, Signaling a New Era of Commercial Independence

You may have missed

the-rise-of-the-non-opioid-frontier-latigo-biotherapeutics-leads-a-biotech-ipo-renaissance

The Rise of the Non-Opioid Frontier: Latigo Biotherapeutics Leads a Biotech IPO Renaissance

Nana Wu August 7, 2026
the-economics-of-access-how-medicaid-reimbursement-shapes-the-post-dobbs-abortion-landscape

The Economics of Access: How Medicaid Reimbursement Shapes the Post-Dobbs Abortion Landscape

Lina Hope August 7, 2026
protecting-the-pipeline-metavivor-challenges-proposed-revisions-to-federal-research-funding

Protecting the Pipeline: METAvivor Challenges Proposed Revisions to Federal Research Funding

Laily UPN August 7, 2026
the-genomic-revolution-cultivating-the-future-of-the-peanut-industry

The Genomic Revolution: Cultivating the Future of the Peanut Industry

Nana Muazin August 7, 2026